Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Tisagenlecleucel Safety for Cancer
Recruiting2 awardsPhase 3
This trial will study the safety of a drug that doesn't meet specification for release. It will specifically study the safety of the drug in Japanese patients in two parts. Part one will also study the efficacy of the drug.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service